DYN

Dyne Therapeutics, Inc. is an innovative biotechnology company based in Waltham, Massachusetts, dedicated to revolutionizing the treatment of genetically-driven muscle diseases through its proprietary muscle-targeted delivery platform. The firm is advancing a robust pipeline of therapeutic candidates aimed at addressing significant unmet medical needs in this specialized field. With a strong focus on developing impactful therapies, Dyne Therapeutics is well-positioned to enhance patient outcomes and improve the quality of life for individuals suffering from muscle disorders, making it a compelling investment opportunity within the biotechnology sector.